AC Immune SA (ACIU)

• This is a Switzerland-based company with focused on neurodegenerative diseases.
• With no treatmeant to Alzheimer's disease is my main reason to invest in this stock. High risk vs high reward.
• Two recent news partnership/collaboration with Lilly and WuXi Biologics.
• Catalyst 2019/2020 data.
• Price Target $20.00+ is my personal target.
• Do you own due diligence. 

Disclosure. I am long.